BCAB Competitors & Alternatives
Compare Bioatla Inc with similar stocks in the same industry
Biotechnology
BCAB
Main Stock$3.18
Tradestie Score
48
Market Cap
$39.57M
Revenue Growth
0.3%
Analyst Upside
+214.5%
Top Competitors
240 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$17.28
|
$133.50M | - | 33 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.53
|
$114.01M | - | 46 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$34.28
|
$110.20M | - | 34 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.80
|
$97.42M | - | 44 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$2.04
|
$96.93M | - | 53 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$6.63
|
$85.47M | - | 43 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.23
|
$84.52M | - | 45 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$4.63
|
$71.69M | - | 48 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$10.93
|
$71.32M | - | 47 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$13.66
|
$67.94M | - | 41 | Compare |
More BCAB Analysis
Data updated: Aug 22, 2026 | Industry: Biotechnology (SIC 2836)
240 stocks in this industry